NCT04745078

Completed

Carboxytherapy for Periorbital Dark Circles

Alexandria University Source

Compare

Other study identifiers

Sponsor study identifier

0104074

Study Type

interventional

Actual enrollment (reported)

80

Locations

1 country

Sites

1

Timeline

Study Start

January 1, 2017

Actual (reported)

Primary Completion

April 1, 2021

Actual (reported)

Study Completion

May 15, 2021

Actual (reported)

Brief Summary

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 80 participants
Study completion date: May 15, 2021
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 1, 2017
Actual (reported)
First Submitted
February 3, 2021
Actual (reported)
First Posted
February 9, 2021
Actual (reported)
Primary Completion
April 1, 2021
Actual (reported)
Study Completion
May 15, 2021
Actual (reported)

Last Updated: November 4, 2021
Status Verified: November 2021
Last Update Submitted: November 2, 2021

Conditions

Periorbital Disorder

Keywords

carboxytherapydark circles

Outcome Measures

Primary Outcomes (2)

Improvement of Melanin index
change in melanin index of the dark circles
6 weeks
Improvement of erythema index
change in erythema index of the dark circles
6 weeks

Study Arms (2)

Carboxy30

ACTIVE COMPARATOR

carboxy30

Other: Caboxy30

Carboxy60

ACTIVE COMPARATOR

carboxy60

Other: Caboxy60

Interventions

Caboxy30Other

carboxy30 to periorbital dark halos

Also known as: Carboxy30

Carboxy30

Caboxy60Other

carboxy60 to periorbital dark halos

Carboxy60

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

healthy individuals with dark circles

You may not qualify if:

Sponsors & Collaborators

Alexandria University
Otherlead

Study Sites (1)

Faculty of Medicine,Alexandria University

Alexandria, Egypt

Study Officials

Ossama H Roushdy, MD
University of Alexandria
STUDY CHAIR

Enrollment

80 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: principal investigator

Study Record Dates

First Submitted

February 3, 2021

First Posted

February 9, 2021

Study Start

January 1, 2017

Actual (reported)

infections, scarring, pregnancy, allergy, on treatment for the condition.

Contact the study team to confirm eligibility.

Primary Completion

April 1, 2021

Actual (reported)

Study Completion

May 15, 2021

Actual (reported)

Last Updated

November 4, 2021

Record last verified: 2021-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04745078
Data provider: ClinicalTrials.gov
Source updated: 2021-11-04
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:39 UTC

Locations

EG(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

Carboxy30

Carboxy60

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations